Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
pure give pectin 20g/d for five days
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Inflammatory Bowel Disease
1 trial -
remimazolam
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthetic Drug Adverse Reaction
1 trial -
remimazolam combined with remifentanil
The First People's Hospital of Lianyungang
Difficult or Failed Intubation
1 trial -
repetitive transcranial magnetic stimulation (rTMS)
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine Addiction
1 trial -
rhBMP-2 placement
ADIAL PHARMACEUTICALS, INC.
Tooth Loss
1 trial -
rice formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
salbutamol
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina, Stable
1 trial -
sevelamer hydrochloride
The University of Hong Kong
Endstage Renal Disease
1 trial -
simiaowan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gout Flare
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
substructure informed planning
United Therapeutics Europe Ltd
Brain Tumor
1 trial -
tacrolimus
The First People's Hospital of Lianyungang
Renal Transplantation
1 trial -
tested formula with fiber
United Therapeutics Europe Ltd
Atopic Dermatitis
1 trial -
the ginsenoside Rg3
The First People's Hospital of Lianyungang
Stage I Hepatocellular Carcinoma
1 trial -
traditional chinese medicine Xuanfei-Zhike formula
The First People's Hospital of Lianyungang
Cough Variant Asthma
1 trial -
tranexamic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Transplantation
1 trial -
zanubrutinib, bendamustine, and obinutuzumab
The First People's Hospital of Lianyungang
Follicular Lymphoma
1 trial -
Ξ³-globin reactivated autologous hematopoietic stem cells
The First People's Hospital of Lianyungang
Thalassemia Major
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources